Global At-Home Health Testing Market Overview:
At-home medical tests are kits that can be purchased online or at a local pharmacy or supermarket. The kits allow you to test for, screen for, or monitor certain diseases and conditions in the comfort of your own home. At-home testing is a growing part of health care that, like telemedicine, has gained popularity during the COVID-19 pandemic. Direct-to-consumer (DTC) at-home tests cover a wide range of test types. Pregnancy tests, glucose tests, faecal occult blood tests, infectious disease tests, and many other common at-home tests.
Growth Drivers
- Increase in Adoption of Self-Help and Do-It-Yourself (DIY) Test Kits
- Growing Demand of Self-Diagnosis for Diabetes
Roadblocks
- High Cost of Home Test Kits
Opportunities
- Increasing Demand for Point-of-Care Diagnostics
- Rising Concerns of Infectious Diseases
Challenges
- Home Test Kits are Limited to taking Sample Blood and Saliva
- Lack of Trained Professional to Perform Proper Tests
Competitive Landscape:
The demand for At-Home Health Testing is increasing. Businesses in this sector face global competition from market leaders who control a large share of the market. Companies are differentiating their products from competition by employing environmentally friendly materials and manufacturing techniques. The Leading Players are engaging in strategic global expansion to maintain their Market Position. Players are expected to focus on the creation of new compounds, which would likely drive the worldwide market forward over the forecast period.
Some of the key players profiled in the report are Roche Holding AG (Switzerland), Siemens Healthineers (Germany), Thermo Fisher Scientific (United States), BD (United States), Abbott Laboratories (United States), Synlab Group (Germany), Quidel Corporation, Everly Well, Inc. (United States), Chembio Diagnostics (United States), Cardinal Health (United States) and Biosynex (France). Additionally, following companies can also be profiled that are part of our coverage like bioLytical Laboratories Inc (Canada) and Viracor-IBT Laboratories (United States). Analyst at AMA Research see United States Players to retain maximum share of Global At-Home Health Testing market by 2027. Considering Market by Usage, the sub-segment i.e. Disposable will boost the At-Home Health Testing market. Considering Market by Distribution Channel, the sub-segment i.e. Online {Brand Website, E-Commerce Website} will boost the At-Home Health Testing market. Considering Market by Sample Type, the sub-segment i.e. Blood will boost the At-Home Health Testing market. Considering Market by Form Type, the sub-segment i.e. Cassette will boost the At-Home Health Testing market. Considering Market by Test Type, the sub-segment i.e. Glucose Monitoring Devices will boost the At-Home Health Testing market.
In October 2020 Thermo Fisher Scientific had announced the expansion of Emergency Use Authorization (EUA) for the TaqPath COVID-19 Combo Kit. Samples collected with the Everlywell self-collection kit can be processed by CLIA-certified laboratories using Thermo Fisher's TaqMan SARS-CoV-2 RNase P Assay Kit, and the results can be accessed via the Everlywell online platform. This more convenient sample processing experience at home is expected to increase access to highly accurate PCR-based testing.
What Can be Explored with the At-Home Health Testing Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global At-Home Health Testing Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in At-Home Health Testing
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global At-Home Health Testing market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in At-Home Health Testing market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture and Capitalist, New entrants/investors, Analysts and Strategic Business Partners, Hospitals, Clinics, Residential Sector and End-use industries.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.